Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;146(4):1079-1088.
doi: 10.1007/s00432-020-03141-w. Epub 2020 Feb 8.

Guidelines for uveal melanoma: a critical appraisal of systematically identified guidelines using the AGREE II and AGREE-REX instrument

Affiliations

Guidelines for uveal melanoma: a critical appraisal of systematically identified guidelines using the AGREE II and AGREE-REX instrument

Theresa Steeb et al. J Cancer Res Clin Oncol. 2020 Apr.

Abstract

Purpose: Clinical practice guidelines provide recommendations for the management of diseases. In orphan conditions such as uveal melanoma (UM), guideline developers are challenged to provide practical and useful guidance even in the absence of high-quality evidence. Here, we assessed the methodological quality and identified deficiencies of international guidelines on UM as a base for future guideline development.

Methods: A systematic search was carried out in guideline databases, Medline and Embase until 27th May 2019 for guidelines on UM published between 2004 and 2019. Five independent reviewers assessed the methodological quality of the identified guidelines using the instruments "Appraisal of Guidelines for Research and Evaluation II" (AGREE II) and AGREE-REX (Recommendation EXcellence). Descriptive analysis was performed and subgroup differences were explored with the Kruskal-Wallis (H) test. The relationship between the individual domains and items of the instruments were examined using Spearman's correlation.

Results: Five guidelines published from 2014 to 2018 by consortia of the United States of America, Canada and the United Kingdom (UK) were included. The highest scores were obtained by the UK guideline fulfilling 48-86% of criteria in AGREE II and 30-60% for AGREE-REX. All guidelines showed deficiencies in the domains "editorial independence", "applicability", and "recommendation". Subgroup differences were identified only for the domain "editorial independence".

Conclusion: The UK guideline achieved the highest scores with both instruments and may serve as a basis for future guideline development in UM. The domains "editorial independence", "recommendation", and "applicability" were identified as methodological weaknesses and require particular attention and improvement in future guidelines.

Keywords: AGREE; Guideline; Ocular melanoma; Orphan disease; Practice guideline; Uveal melanoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Flow chart of the guideline identification process according to the PRISMA guidelines
Fig. 2
Fig. 2
Heat-map showing an overview of the final AGREE II and AGREE-REX scores on UM guidelines as agreed upon by five independent evaluators
Fig. 3
Fig. 3
Network comparing the five different guidelines regarding the AGREE II (a) and AGREE REX (b) domains

References

    1. Agarwala SS, Eggermont AM, O'Day S, Zager JS (2014) Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options. Cancer 120:781–789. 10.1002/cncr.28480 - DOI - PubMed
    1. AGREE-REX Research Team (2019). The Appraisal of Guidelines Research & Evaluation—Recommendation EXcellence (AGREE-REX) [Electronic version]. https://www.agreetrust.org/wp-content/uploads/2019/04/AGREE-REX-2019.pdf. Accessed 18 Nov 2019
    1. Barker CA, Salama AK (2018) New NCCN guidelines for uveal melanoma and treatment of recurrent or progressive distant metastatic melanoma. J Natl Compr Cancer Netw 16:646–650. 10.6004/jnccn.2018.0042 - DOI - PubMed
    1. Bedikian AY (2006) Metastatic uveal melanoma therapy: current options. Int Ophthalmol Clin 46:151–166 - DOI - PubMed
    1. Boffin N, Swinnen E, Wens J, Urbina M, Van der Heyden J, Van Casteren V (2018) General practice care for patients with rare diseases in Belgium A Cross-Sectional Survey. Int J Environ Res Public Health. 10.3390/ijerph15061180 - DOI - PMC - PubMed